CCO Oncology Podcast

Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Spain

Episode Summary

Listen to Félix Guerrero Ramos, MD, PhD, FEBU, and Óscar Rodríguez-Faba, MD, discuss in Spanish the latest clinical data on immune checkpoint inhibitors for advanced urothelial cancer.

Episode Notes

In this episode, Félix Guerrero Ramos, MD, PhD, FEBU, and Óscar Rodríguez-Faba, MD, discuss in Spanish the latest immuno-oncology developments in the treatment of urothelial cancer. 

Presenters:

Félix Guerrero Ramos, MD, PhD, FEBU 
Teaching Collaborator
Department of Surgery
Medicine School
Universidad Complutense de Madrid
Attending Urologist
Department of Urology
UroOncology Unit
Madrid, Spain 

Óscar Rodríguez-Faba, MD 
Urologist
Uro-Oncology
Fundació Puigvert
Barcelona, Catalonia, Spain

Content based on an online IME program supported by educational grants from EMD Serono, Inc and Pfizer.

Link to full program, including associated downloadable slidesets and on-demand Webcast:
http://bit.ly/3kJC5SL